Impact of formulary restrictions on patient safety.
Lazarus
Arthur
A
Clinical Research, AstraZeneca Pharmaceuticals, Wilmington, DE, USA. arthur.lazarus@astrazeneca.com
D005569:Formularies as Topic; D008329:Managed Care Programs; D010818:Practice Patterns, Physicians'; D011787:Quality of Health Care; D017751:Safety Management; D014481:United States